Safety and Efficacy of 1% and 3% Topical Minocycline Gel in Patients With Papulopustular Rosacea
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Multicenter, Randomized, Double-Masked, Parallel Group, Vehicle-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of 1% and 3% Topical Minocycline Gel in Patients With Papulopustular Rosacea
Br J Dermatol 2020 Jan 06;[EPub Ahead of Print], G Webster, ZD Draelos, E Graber, MS Lee, S Dhawan, M Salman, GN MagrathFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.